Dadkar N K, Aroskar V A, Gupte R D, Dohadwalla A N
J Pharm Pharmacol. 1985 May;37(5):372-4. doi: 10.1111/j.2042-7158.1985.tb05090.x.
The H2-receptor antagonist cimetidine (250 micrograms) administered intracerebroventricularly (i.c.v.) 15 and 30 min before clonidine (25 micrograms kg-1 i.v.), significantly antagonized clonidine-induced hypotension in anaesthetized spontaneously hypertensive rats. The hypertensive response of cimetidine was correlated with the inhibition of clonidine-induced hypotension. In addition, cimetidine (250 micrograms i.c.v.) counteracted the hypotensive effects of pentolinium (5.0 mg kg-1 i.v.), guanethidine (5.0 mg kg-1 i.v.) and minoxidil (1.0 mg kg-1 i.v.) These data do not support previous suggestions that the hypotensive action of clonidine is caused by stimulation of the H2-receptor, but suggest that central administration of cimetidine causes peripheral vasoconstriction and this may offer resistance to the hypotensive action of different antihypertensive agents.
在可乐定(25微克/千克静脉注射)前15分钟和30分钟经脑室注射(i.c.v.)250微克H2受体拮抗剂西咪替丁,可显著拮抗麻醉的自发性高血压大鼠中可乐定诱导的低血压。西咪替丁的高血压反应与可乐定诱导的低血压的抑制相关。此外,西咪替丁(250微克i.c.v.)抵消了潘托铵(5.0毫克/千克静脉注射)、胍乙啶(5.0毫克/千克静脉注射)和米诺地尔(1.0毫克/千克静脉注射)的降压作用。这些数据不支持先前关于可乐定降压作用是由H2受体刺激引起的观点,而是表明经中枢给予西咪替丁会导致外周血管收缩,这可能会抵抗不同降压药物的降压作用。